Literature DB >> 10078554

Structure and promoter activity of an islet-specific glucose-6-phosphatase catalytic subunit-related gene.

D H Ebert1, L J Bischof, R S Streeper, S C Chapman, C A Svitek, J K Goldman, C E Mathews, E H Leiter, J C Hutton, R M O'Brien.   

Abstract

In liver and kidney, the terminal step in the gluconeogenic pathway is catalyzed by glucose-6-phosphatase (G-6-Pase). This enzyme is actually a multicomponent system, the catalytic subunit of which was recently cloned. Numerous reports have also described the presence of G-6-Pase activity in islets, although the role of G-6-Pase in this tissue is unclear. Arden and associates have described the cloning of a novel cDNA that encodes an islet-specific G-6-Pase catalytic subunit-related protein (IGRP) (Arden SD, Zahn T, Steegers S, Webb S, Bergman B, O'Brien RM, Hutton JC: Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit related protein (IGRP). Diabetes 48:531-542, 1999). We screened a mouse BAC library with this cDNA to isolate the IGRP gene, which spans approximately 8 kbp of genomic DNA. The exon/intron structure of the IGRP gene has been mapped and, as with the gene encoding the liver/kidney G-6-Pase catalytic subunit, it is composed of five exons. The sizes of these exons are 254 (I), 110 (II), 112 (III), 116 (IV), and 1284 (V) bp, similar to those of the G-6-Pase catalytic subunit gene. Two interspecific backcross DNA mapping panels were used to unambiguously localize the IGRP gene (map symbol G6pc-rs) to the proximal portion of mouse chromosome 2. The IGRP gene transcription start site was mapped by primer extension analysis, and the activity of the IGRP gene promoter was analyzed in both the islet-derived HIT cell line and the liver-derived HepG2 cell line. The IGRP and G-6-Pase catalytic subunit gene promoters show a reciprocal pattern of activity, with the IGRP promoter being approximately 150-fold more active than the G-6-Pase promoter in HIT cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10078554     DOI: 10.2337/diabetes.48.3.543

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  A genomewide search for type 2 diabetes-susceptibility genes in indigenous Australians.

Authors:  Frances Busfield; David L Duffy; Janine B Kesting; Shelley M Walker; Paul K Lovelock; David Good; Heather Tate; Denise Watego; Maureen Marczak; Noel Hayman; Joanne T E Shaw
Journal:  Am J Hum Genet       Date:  2001-12-12       Impact factor: 11.025

2.  A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes.

Authors:  John C Hutton; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

3.  G6PC2 Modulates Fasting Blood Glucose In Male Mice in Response to Stress.

Authors:  Kayla A Boortz; Kristen E Syring; Chunhua Dai; Lynley D Pound; James K Oeser; David A Jacobson; Jen-Chywan Wang; Owen P McGuinness; Alvin C Powers; Richard M O'Brien
Journal:  Endocrinology       Date:  2016-06-14       Impact factor: 4.736

4.  Effects of G6pc2 deletion on body weight and cholesterol in mice.

Authors:  Kayla A Boortz; Kristen E Syring; Lynley D Pound; Huan Mo; Lisa Bastarache; James K Oeser; Owen P McGuinness; Joshua C Denny; Richard M O'Brien
Journal:  J Mol Endocrinol       Date:  2017-01-25       Impact factor: 5.098

Review 5.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

6.  Upstream stimulatory factor (USF) and neurogenic differentiation/beta-cell E box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression.

Authors:  Cyrus C Martin; Christina A Svitek; James K Oeser; Eva Henderson; Roland Stein; Richard M O'Brien
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

7.  Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels.

Authors:  D A Baerenwald; A Bonnefond; N Bouatia-Naji; B P Flemming; O C Umunakwe; J K Oeser; L D Pound; N L Conley; S Cauchi; S Lobbens; E Eury; B Balkau; O Lantieri; P K Dadi; D A Jacobson; P Froguel; R M O'Brien
Journal:  Diabetologia       Date:  2013-03-19       Impact factor: 10.122

8.  Moving on from GWAS: functional studies on the G6PC2 gene implicated in the regulation of fasting blood glucose.

Authors:  Richard M O'Brien
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

9.  Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression.

Authors:  Cyrus C Martin; Brian P Flemming; Yingda Wang; James K Oeser; Richard M O'Brien
Journal:  J Mol Endocrinol       Date:  2008-08-27       Impact factor: 5.098

10.  A single-nucleotide polymorphism in a methylatable Foxa2 binding site of the G6PC2 promoter is associated with insulin secretion in vivo and increased promoter activity in vitro.

Authors:  Christine Dos Santos; Pierre Bougnères; Delphine Fradin
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.